We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

105 hedge funds and large institutions have $212M invested in Foghorn Therapeutics in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 9

90% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 21

13% more funds holding

Funds holding: 93 → 105 (+12)

1.66% more ownership

Funds ownership: 74.05% → 75.71% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less capital invested

Capital invested by funds: $226M → $212M (-$13.7M)

Holders
105
Holders Change
+12
Holders Change %
+12.9%
% of All Funds
1.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
40
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DM
Deerfield Management
New York
+$4.09M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.57M
3
BI
BVF Inc
California
+$2.96M
4
CS
Candriam SCA
Luxembourg
+$1.72M
5
WP
Woodline Partners
California
+$872K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$983K
2
Ameriprise
Ameriprise
Minnesota
-$871K
3
Jane Street
Jane Street
New York
-$716K
4
Walleye Capital
Walleye Capital
New York
-$257K
5
Barclays
Barclays
United Kingdom
-$240K
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$60.6M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$28.9M +$3.57M +650,384 +12%
BI
3
BVF Inc
California
$27.9M +$2.96M +540,000 +10%
DM
4
Deerfield Management
New York
$21M +$4.09M +745,156 +20%
Raymond James Financial
5
Raymond James Financial
Florida
$12.4M +$530K +96,561 +4%
BlackRock
6
BlackRock
New York
$11.3M +$82.3K +14,996 +0.6%
EC
7
Euclidean Capital
New York
$7.52M – – –
VCM
8
Vanguard Capital Management
Pennsylvania
$7.15M +$8.21M +1,495,089 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$4.06M +$292K +53,132 +7%
SL
10
Siren LLC
Connecticut
$3.45M – – –
State Street
11
State Street
Massachusetts
$3.25M +$336K +61,121 +10%
Ameriprise
12
Ameriprise
Minnesota
$2.15M -$871K -158,694 -26%
Renaissance Technologies
13
Renaissance Technologies
New York
$1.94M +$597K +108,689 +37%
CS
14
Candriam SCA
Luxembourg
$1.5M +$1.72M +313,765 New
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$1.45M +$190K +34,571 +13%
BC
16
Birchview Capital
Vermont
$1.35M – – –
Northern Trust
17
Northern Trust
Illinois
$1.32M +$73.8K +13,445 +5%
VPM
18
Vanguard Portfolio Management
Pennsylvania
$1.22M +$1.41M +255,931 New
VFT
19
Vanguard Fiduciary Trust
Pennsylvania
$1.15M +$1.32M +240,586 New
Citadel Advisors
20
Citadel Advisors
Florida
$956K +$97.4K +17,737 +10%
WP
21
Woodline Partners
California
$862K +$872K +158,810 +738%
Goldman Sachs
22
Goldman Sachs
New York
$651K +$95.6K +17,407 +15%
SCM
23
Sio Capital Management
New York
$587K – – –
PAM
24
Panagora Asset Management
Massachusetts
$550K +$141K +25,768 +29%
DCM
25
DAFNA Capital Management
California
$535K -$82.3K -15,000 -12%
1
2 3 4 5

FHTX Hedge Fund Activity: Q1 2026 in Review

105 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q1 2026, worth a combined $212M — down 6.1% from $226M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FHTX positions and 9 closed out — a net gain of 13 holders — while 40 added to existing stakes and 21 trimmed.

The largest buyer was Deerfield Management, adding an estimated $4.09M. The largest seller was Millennium Management, cutting an estimated $983K.

  • 105 institutional investors held Foghorn Therapeutics (FHTX) as of Q1 2026, up from 93 in Q4 2025.
  • Funds reported $212M of Foghorn Therapeutics stock for Q1 2026, down 6.1% quarter-over-quarter.
  • 22 funds opened new Foghorn Therapeutics positions in Q1 2026 and 9 closed out, a net change of +13 holders.
  • The largest Foghorn Therapeutics buyer in Q1 2026 was Deerfield Management, an estimated $4.09M added.
  • The largest Foghorn Therapeutics seller in Q1 2026 was Millennium Management, an estimated $983K sold.

Based on aggregated 13F filings for Q1 2026.